BDR looking to buy majority stake in drug plant in Belarus

BDR will be investing $13 million in the Belarus facility. In addition, it is also investing in setting up a formulation manufacturing unit in Algeria to make anti-cancer medication at an investment of $12 million.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/G3vcYV5
via IFTTT